article thumbnail

Patients of African heritage have fewer actionable mutations

Drug Discovery World

“However, the extent to which differences in germline or somatic genomic alterations influence outcomes remains unknown.” Genetic sequencing To assess these alterations in groups of different ancestries, Walch and colleagues analysed targeted DNA sequencing data from 4,441 patients treated for colorectal cancer at MSK between 2014 and 2022.

Genome 52